Barbara Domayne-Hayman provides an overview of the Autifony Therapeutics business.
Imperial Innovations commercialises leading UK research and seeks to build substantial, high quality, well-funded and well-managed businesses.
Industry: Financials
Contact: http://www.imperialinnovations.co.uk/
